ONESOURCE - Onesource Specialty Pharma | Wealthrox

GRAVITA ₹ 1854.65 16.5%
AURIONPRO ₹ 1555.6 13.8%
SARDAEN ₹ 467.75 11.6%
TVSHLTD ₹ 8973.2 11.2%
SYRMA ₹ 481.35 11.2%
JUBLPHARMA ₹ 919.15 11.0%
ATUL ₹ 5728.55 10.6%
LTFOODS ₹ 354.0 10.2%
WOCKPHARMA ₹ 1319.3 10.0%
PIIND ₹ 3610.6 9.6%
BLUEJET ₹ 686.85 9.5%
SUVENPHAR ₹ 1149.5 9.3%
WELSPUNLIV ₹ 123.85 9.1%
PRUDENT ₹ 2264.65 9.1%
TIMKEN ₹ 2474.95 9.0%
MUTHOOTFIN ₹ 2017.35 5.7%
BGDL ₹ 1174.65 5.0%
ICICIGI ₹ 1718.35 3.7%
JSWHL ₹ 23188.0 3.4%
JYOTHYLAB ₹ 367.05 3.3%
MAXHEALTH ₹ 1089.25 3.1%
ICICIPRULI ₹ 553.1 2.7%
KFINTECH ₹ 999.2 2.6%
ITDCEM ₹ 525.25 2.5%
EUREKAFORB ₹ 501.9 2.2%
AEGISLOG ₹ 756.5 2.1%
SWIGGY ₹ 332.75 2.0%
AGARWALEYE ₹ 415.0 1.8%
SUNDARMFIN ₹ 4670.4 1.6%
ASTRAL ₹ 1248.5 1.4%

Login

Onesource Specialty Pharma

ONESOURCE · Pharma > Pharmaceuticals & Drugs Listing date: Jan. 24, 2025

Stock Price vs Company Growth

1d

1.3%

1w

0.5%

1m

0.2%

all

11.6%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,504 1.3%

1,163

1,774

Company Overview

Sales

550 Cr

Growth: 95.5%

Profit after Tax

-352 Cr

Growth: -11.3%

Mid Cap

17,216 Cr

P/S: 31.3x

Industry P/S: 2.6x

Fundamentals

Sales (Cr)	₹ 550
Growth	95.5%
EBITDA	17.1%
P/S	31.3x
Dividend	0.0%
P/E	-20.0x
Book Value	₹ 1
PEG Ratio	-0.2x
ROE	-5958.5%
P/B	N/A

Shareholding Pattern

Institutions

Promoters

Others

Increase Decrease No change

Company Profile Detailed

OneSource Specialty Pharma is a multimodal specialty pharma CDMO with end-to-end capabilities across technology platforms and therapeutic modalities.